Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Academic and Community Cancer Research United (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (2)

lenvatinib (1)

lenvatinib mesylate (1)

pazopanib hydrochloride (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (2)

other (2)

biological (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

stage iii differentiated thyroid gland carcinoma ajcc v7

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting

Columnar Cell Variant Thyroid Gland Papillary Carcinoma
+25 more

Laboratory Biomarker Analysis
+3 more

Torrance, California
+6 more

Jan 12, 2023

Recurrent Thyroid Gland Carcinoma, Stage III Differentiated Thyroid Gland Carcinoma AJCC v7, Stage III Thyroid Gland Medullary

Completed

Recurrent Thyroid Gland Carcinoma
+12 more

Laboratory Biomarker Analysis
Pazopanib Hydrochloride

Scottsdale, Arizona
+21 more

Feb 4, 2020